Agilon Health (AGL) Depreciation & Amortization (CF) (2020 - 2026)

Agilon Health (AGL) has reported Depreciation & Amortization (CF) for 7 consecutive years, with $6.8 million the latest figure, recorded in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $6.8 million, down 1.29% year-over-year; the trailing twelve-month figure through Mar 2026 was $28.5 million (up 11.81% YoY), and the FY2025 annual result was $28.6 million, up 16.89% from the prior year.
• Depreciation & Amortization (CF) was $6.8 million for Q1 2026 at Agilon Health, down from $7.0 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $7.4 million in Q3 2025 and troughed at $3.0 million in Q2 2022.
• Average Depreciation & Amortization (CF) over 5 years is $5.5 million, with a median of $5.8 million recorded in 2024.
• Year-over-year, Depreciation & Amortization (CF) retreated 15.83% in 2022 and jumped 81.3% in 2023.
• Over 5 years, Depreciation & Amortization (CF) stood at $3.9 million in 2022, then surged by 31.74% to $5.1 million in 2023, then rose by 26.17% to $6.5 million in 2024, then gained by 7.31% to $7.0 million in 2025, then fell by 2.61% to $6.8 million in 2026.
• Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $6.8 million in Q1 2026, $7.0 million in Q4 2025, and $7.4 million in Q3 2025.